June 29, 2026

Oscar Health, Inc. (OSCR) Stock Analysis: Exploring the 52.60% Revenue Growth in the Expanding Healthcare Sector

Oscar Health, Inc. (OSCR) is making waves in the healthcare sector, capturing investor attention with an impressive 52.60% revenue growth. Headquartered in New York, Oscar Health operates as a healthcare..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotech Marvel with 31.9% Revenue Growth and Strong Buy Ratings

Krystal Biotech, Inc. (NASDAQ: KRYS) has emerged as a formidable player in the biotechnology sector, with a market capitalization of $10.97 billion. Specializing in genetic medicines targeting diseases with significant..

HealthEquity, Inc. (HQY) Stock Analysis: Strong Buy Ratings Signal a Potential 30% Upside for Investors

HealthEquity, Inc. (NASDAQ: HQY), a leader in the Health Information Services industry, is capturing the attention of investors with its robust growth potential and favorable analyst ratings. Based in Draper,..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Potential Upside Amidst Market Challenges

Avantor, Inc. (NYSE: AVTR) stands as a pivotal player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $7.02 billion, Avantor provides..

Tempus AI, Inc. (TEM) Stock Analysis: Growth Prospects Amidst a Complex Financial Landscape

Tempus AI, Inc. (TEM), a healthcare technology company headquartered in Chicago, Illinois, is making waves in the health information services industry with its innovative solutions and strategic collaborations. With a..

DaVita Inc. (DVA) Stock Analysis: Evaluating the Healthcare Giant’s 80.98% ROE and Market Dynamics

DaVita Inc. (NYSE: DVA), a leader in the healthcare sector with a focus on medical care facilities, has been a subject of keen investor interest, particularly given its impressive return..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating a 11.37% Potential Upside Amidst Mixed Analyst Ratings

Inspire Medical Systems, Inc. (NASDAQ: INSP) has been capturing investor attention as it operates at the cutting edge of medical technology, particularly in the treatment of obstructive sleep apnea (OSA)...

Cytokinetics, Incorporated (CYTK): Investor Outlook Reveals 28.48% Upside in Biotech

Cytokinetics, Incorporated (NASDAQ: CYTK), a leading player in the biotechnology sector, has captured the attention of investors with its robust revenue growth and promising drug pipeline. With a current market..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 14% Potential Upside in the Healthcare Sector

Becton, Dickinson and Company (NYSE: BDX) stands as a formidable entity in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $42.96 billion, BDX has..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Unraveling a $38.71 Billion Biotechnology Powerhouse’s Growth Potential

Revolution Medicines, Inc. (NASDAQ: RVMD) is carving its niche in the healthcare sector, particularly in the biotechnology industry. With its focus on developing groundbreaking therapies for RAS-addicted cancers, the company..

Sarepta Therapeutics (SRPT) Stock Analysis: Unveiling a 30% Potential Upside in the Biotech Sector

Sarepta Therapeutics, Inc. (SRPT), a leading name in the biotechnology sector, is making waves with its focus on RNA-targeted therapeutics and gene therapy for rare diseases. With a market capitalization..

TransMedics Group, Inc. (TMDX) Stock Analysis: Healthcare Innovator with 71.44% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX) is capturing investor attention with its innovative approach to organ transplant therapy and a notable potential upside of 71.44%, according to recent analyst ratings. Specializing..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Strong Buy Ratings Signal Potential Upside in Biotech Sector

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a prominent player in the biotechnology sector, is making waves with its innovative approach to treating central nervous system (CNS) disorders. Based in New York..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 9% Upside Potential Amid Diverse Healthcare Offerings

Viatris Inc. (NASDAQ: VTRS) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry focused on specialty and generic medications. With a market capitalization of..

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 21.24% Potential Upside in the Healthcare Information Sector

For investors seeking opportunities within the healthcare information services industry, Doximity, Inc. (NYSE: DOCS) presents an intriguing case. With a market capitalization of $3.82 billion, this San Francisco-based company operates..

Telix Pharmaceuticals Limited (TLX): Analyst Ratings Reveal a Potential 91.73% Upside for Investors

Telix Pharmaceuticals Limited (TLX), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising financial and operational metrics. Based in North Melbourne, Australia, Telix..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 17% Potential Upside

Align Technology, Inc. (NASDAQ: ALGN), a leader in the medical instruments and supplies industry, continues to capture the attention of investors with its innovative solutions in orthodontics and digital dentistry...

Corcept Therapeutics (CORT) Investor Outlook: Navigating Growth in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) is capturing investor attention with its promising position in the biotechnology sector. With a market capitalization of $9.37 billion, the company is focused on the..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Unpacking a 19% Revenue Growth and a Promising 11.73% Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a notable player in the biotechnology sector, presents a compelling investment opportunity, driven by robust revenue growth and a promising upside potential. Headquartered in Dublin,..

Masimo Corporation (MASI) Stock Analysis: Exploring Stability in Volatile Markets with a 24.99% ROE

Masimo Corporation (NASDAQ: MASI), a prominent player in the medical devices sector, is catching the attention of investors with its robust financial performance and strategic product offerings. Headquartered in Irvine,..

Search

Funds

June 29, 2026

Search

Funds

June 29, 2026

FTSE 100

Funds